2'-deoxycytidine 5'-triphosphate has been researched along with Ovarian Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdul-Karim, FW; Abulafia, O; Bonebrake, AJ; Fanning, J; Kunos, C; Radivoyevitch, T; Usha, L | 1 |
| Guechev, A; Loves, WJ; Peters, GJ; Pinedo, HM; Postmus, PE; Smid, K; van Moorsel, CJ; Veerman, G; Vermorken, JB | 1 |
1 trial(s) available for 2'-deoxycytidine 5'-triphosphate and Ovarian Neoplasms
| Article | Year |
|---|---|
Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study.
Topics: Adult; Aged; Cell Line, Tumor; Cell Survival; Deoxycytosine Nucleotides; DNA Damage; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Gynecology; Histones; Humans; Immunoblotting; Medical Oncology; Middle Aged; Ovarian Neoplasms; Platinum; Pyridines; Ribonucleotide Reductases; Thiosemicarbazones; Treatment Outcome | 2012 |
1 other study(ies) available for 2'-deoxycytidine 5'-triphosphate and Ovarian Neoplasms
| Article | Year |
|---|---|
Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Deoxycytosine Nucleotides; DNA Damage; Drug Synergism; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Ovarian Neoplasms; Tumor Cells, Cultured | 1999 |